Annual Total Liabilities
$48.93 M
+$30.42 M+164.38%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual total liabilities is currently $48.93 million, with the most recent change of +$30.42 million (+164.38%) on 31 December 2023. During the last 3 years, it has risen by +$38.40 million (+364.47%). TNXP annual total liabilities is now at all-time high.TNXP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$20.78 M
-$7.43 M-26.33%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly total liabilities is currently $20.78 million, with the most recent change of -$7.43 million (-26.33%) on 30 September 2024. Over the past year, it has increased by +$2.33 million (+12.62%). TNXP quarterly total liabilities is now -57.54% below its all-time high of $48.93 million, reached on 31 December 2023.TNXP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +164.4% | +12.6% |
| 3 y3 years | +364.5% | +65.5% |
| 5 y5 years | +1743.0% | +759.7% |
TNXP Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +364.5% | -57.5% | +65.5% |
| 5 y | 5 years | at high | +1743.0% | -57.5% | +759.7% |
| alltime | all time | at high | >+9999.0% | -57.5% |
Tonix Pharmaceuticals Holding Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.78 M(-26.3%) |
| June 2024 | - | $28.20 M(+3.7%) |
| Mar 2024 | - | $27.20 M(-44.4%) |
| Dec 2023 | $48.93 M(+164.4%) | $48.93 M(+165.2%) |
| Sept 2023 | - | $18.45 M(-4.3%) |
| June 2023 | - | $19.27 M(+41.1%) |
| Mar 2023 | - | $13.66 M(-26.2%) |
| Dec 2022 | $18.51 M(-16.6%) | $18.51 M(+34.9%) |
| Sept 2022 | - | $13.72 M(-16.2%) |
| June 2022 | - | $16.38 M(+4.0%) |
| Mar 2022 | - | $15.76 M(-29.0%) |
| Dec 2021 | $22.18 M(+110.6%) | $22.18 M(+76.7%) |
| Sept 2021 | - | $12.56 M(+44.8%) |
| June 2021 | - | $8.67 M(+31.3%) |
| Mar 2021 | - | $6.61 M(-37.3%) |
| Dec 2020 | $10.54 M(+104.9%) | $10.54 M(+108.7%) |
| Sept 2020 | - | $5.05 M(+5.8%) |
| June 2020 | - | $4.77 M(+77.8%) |
| Mar 2020 | - | $2.69 M(-47.8%) |
| Dec 2019 | $5.14 M(+93.6%) | $5.14 M(+112.7%) |
| Sept 2019 | - | $2.42 M(+10.6%) |
| June 2019 | - | $2.19 M(-1.1%) |
| Mar 2019 | - | $2.21 M(-16.7%) |
| Dec 2018 | $2.65 M(+24.2%) | $2.65 M(+13.2%) |
| Sept 2018 | - | $2.35 M(-6.6%) |
| June 2018 | - | $2.51 M(+6.1%) |
| Mar 2018 | - | $2.37 M(+10.8%) |
| Dec 2017 | $2.14 M(-0.5%) | $2.14 M(+15.3%) |
| Sept 2017 | - | $1.85 M(+0.1%) |
| June 2017 | - | $1.85 M(+2.5%) |
| Mar 2017 | - | $1.81 M(-15.8%) |
| Dec 2016 | $2.15 M | $2.15 M(-20.3%) |
| Sept 2016 | - | $2.70 M(-37.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $4.28 M(+6.9%) |
| Mar 2016 | - | $4.01 M(-40.7%) |
| Dec 2015 | $6.76 M(+95.8%) | $6.76 M(+30.6%) |
| Sept 2015 | - | $5.17 M(+10.5%) |
| June 2015 | - | $4.68 M(+30.7%) |
| Mar 2015 | - | $3.58 M(+3.9%) |
| Dec 2014 | $3.45 M(+55.1%) | $3.45 M(-2.8%) |
| Sept 2014 | - | $3.55 M(+47.9%) |
| June 2014 | - | $2.40 M(+5.3%) |
| Mar 2014 | - | $2.28 M(+2.6%) |
| Dec 2013 | $2.22 M(+92.1%) | $2.22 M(+4.2%) |
| Sept 2013 | - | $2.13 M(-6.3%) |
| June 2013 | - | $2.28 M(+84.6%) |
| Mar 2013 | - | $1.23 M(+6.6%) |
| Dec 2012 | $1.16 M(-59.8%) | $1.16 M(+34.0%) |
| Sept 2012 | - | $864.30 K(+6.6%) |
| June 2012 | - | $810.80 K(-73.2%) |
| Mar 2012 | - | $3.03 M(+5.2%) |
| Dec 2011 | $2.88 M(+700.9%) | $2.88 M(>+9900.0%) |
| Sept 2011 | - | $15.20 K(+12.6%) |
| June 2011 | - | $13.50 K(+7.1%) |
| Mar 2011 | - | $12.60 K(-96.5%) |
| Dec 2010 | $359.50 K(>+9900.0%) | $359.50 K(+9117.9%) |
| Sept 2010 | - | $3900.00(+1200.0%) |
| June 2010 | - | $300.00(0.0%) |
| Mar 2010 | - | $300.00(-70.0%) |
| Dec 2009 | $1000.00(-66.7%) | $1000.00(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | $3000.00 | $3000.00(-93.0%) |
| Sept 2008 | - | $43.00 K(+93.7%) |
| June 2008 | - | $22.20 K(>+9900.0%) |
| Mar 2008 | - | $0.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual total liabilities?
- What is the all time high annual total liabilities for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual total liabilities year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly total liabilities year-on-year change?
What is Tonix Pharmaceuticals Holding annual total liabilities?
The current annual total liabilities of TNXP is $48.93 M
What is the all time high annual total liabilities for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual total liabilities is $48.93 M
What is Tonix Pharmaceuticals Holding annual total liabilities year-on-year change?
Over the past year, TNXP annual total liabilities has changed by +$30.42 M (+164.38%)
What is Tonix Pharmaceuticals Holding quarterly total liabilities?
The current quarterly total liabilities of TNXP is $20.78 M
What is the all time high quarterly total liabilities for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly total liabilities is $48.93 M
What is Tonix Pharmaceuticals Holding quarterly total liabilities year-on-year change?
Over the past year, TNXP quarterly total liabilities has changed by +$2.33 M (+12.62%)